Bacterial Factories Release Checkpoint Inhibitors Locally to Safely Kill Tumors (1 of 1) (IMAGE)
Caption
A schematic showing how engineered bacteria (yellow) controllably release anti-PD-L1 and antiCTLA-4 nanobodies within tumors. This material relates to a paper that appeared in the Feb. 12, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by C.R. Gurbatri at Columbia University in New York, NY; and colleagues was titled, "Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies."
Credit
[Credit: C.R. Gurbatri et al., Science Translational Medicine (2020)]
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content